Adenocyte
Haifa, IL · 1 known investors
Adenocyte develops LINFU (Low Intensity Non-Focused Ultrasound), a minimally invasive ultrasound technology for routine screening of the pancreas to detect pancreatic dysplasia and early-stage pancreatic cancer. The company serves clinical cancer screening for elevated- and average-risk patients, with laboratories in Haifa and Jerusalem and clinical development at the Technion and North American screening centers.
Founders & leadership
MR
Mark RutenbergFounder & CEO
AC
April CarpenterChief Commercial Officer
RH
Robert HarowChief Financial Officer
FS
F. Scott CorbettChief Medical Officer
DE
Drore EisenMedical Research Director
DA
Dan AdamChief Technology Officer
Board
SK
Scott KormanBoard director
Investors · 1
Competitors · 2
by search overlapRarecyte6 shared keywords
Incyte Corporation5 shared keywordsIncyte is a global biopharmaceutical company that develops medicines across hematology, oncology, and inflammation and autoimmunity, with clinical programs spanning areas such as dermatology. It focuses on research and development of treatments for patients.
Companies competing with Adenocyte for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Adenocyte do?
- Adenocyte develops LINFU (Low Intensity Non-Focused Ultrasound), a minimally invasive ultrasound technology for routine screening of the pancreas to detect pancreatic dysplasia and early-stage pancreatic cancer. The company serves clinical cancer screening for elevated- and average-risk patients, with laboratories in Haifa and Jerusalem and clinical development at the Technion and North American screening centers.
- Who founded Adenocyte?
- Adenocyte was founded by Mark Rutenberg.
- Who are Adenocyte's investors?
- Adenocyte's investors include iGan Partners.
- Where is Adenocyte headquartered?
- Adenocyte is headquartered in Haifa, IL.